tiprankstipranks
Kooth (GB:KOO)
LSE:KOO
Want to see GB:KOO full AI Analyst Report?

Kooth (KOO) AI Stock Analysis

23 Followers

Top Page

GB:KOO

Kooth

(LSE:KOO)

Select Model
Select Model
Select Model
Outperform 79 (OpenAI - 5.2)
Rating:79Outperform
Price Target:
177.00 p
▲(53.91% Upside)
Action:Upgraded
Date:05/22/26
The score is driven mainly by strong financial quality (especially a zero-debt balance sheet and improved profitability) and very attractive P/E-based valuation. These positives are tempered by 2025 revenue and cash-flow softness versus 2024 and an overbought technical setup despite a strong uptrend.
Positive Factors
Zero net debt / strong capital base
Near-zero debt and a materially stronger equity base reduce financial distress risk, preserve strategic optionality and allow Kooth to invest in product and clinical safeguards without refinancing pressure. This balance-sheet strength supports durability through tender cycles and slow demand periods.
Negative Factors
2025 revenue decline
A reversal from prior multi-year growth to a revenue decline signals tender timing, contract renewals or demand weakness. Sustained or recurring declines would hinder investment plans, erode scale advantages and pressure margins over the medium term if contract wins soften.
Read all positive and negative factors
Positive Factors
Negative Factors
Zero net debt / strong capital base
Near-zero debt and a materially stronger equity base reduce financial distress risk, preserve strategic optionality and allow Kooth to invest in product and clinical safeguards without refinancing pressure. This balance-sheet strength supports durability through tender cycles and slow demand periods.
Read all positive factors

Kooth (KOO) vs. iShares MSCI United Kingdom ETF (EWC)

Kooth Business Overview & Revenue Model

Company Description
Kooth plc, along with its associated entities, is dedicated to providing digital mental well-being services for children, young people, and adults throughout the United Kingdom. The company maintains an extensive online platform that offers a dive...
How the Company Makes Money
Kooth primarily makes money by contracting with public-sector and public-sector-funded commissioners to provide population-level digital mental health services. Its core revenue stream is business-to-government (and related public commissioning) s...

Kooth Financial Statement Overview

Summary
Fundamentals are solid overall: profitability improved from losses (2020–2023) to positive earnings (2024–2025) and the balance sheet is very strong with zero debt. Offsetting this, 2025 showed a modest revenue decline (-4.6%) and a sharp step-down in operating/free cash flow versus 2024, indicating near-term volatility.
Income Statement
72
Positive
Balance Sheet
88
Very Positive
Cash Flow
64
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue63.29M66.74M33.34M20.12M16.68M
Gross Profit40.09M51.99M25.86M13.86M11.59M
EBITDA10.23M14.53M1.51M1.32M1.65M
Net Income2.61M8.03M-169.00K-716.00K-310.00K
Balance Sheet
Total Assets39.26M43.03M30.68M16.14M13.78M
Cash, Cash Equivalents and Short-Term Investments21.58M21.84M11.00M8.49M7.08M
Total Debt0.0023.00K44.00K68.00K0.00
Total Liabilities7.67M13.28M9.93M5.62M2.81M
Stockholders Equity31.59M29.75M20.76M10.52M10.97M
Cash Flow
Free Cash Flow6.20M17.67M1.58M1.33M-744.00K
Operating Cash Flow6.27M17.79M1.87M4.38M1.85M
Investing Cash Flow-4.45M-6.30M-8.71M-3.05M-2.60M
Financing Cash Flow-1.48M0.009.39M81.00K0.00

Kooth Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
£56.22M21.768.84%-5.18%-66.95%
61
Neutral
£18.86M-4.41-15.57%13.04%15.88%
53
Neutral
£209.39M48.442.09%8.46%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
£516.14K-0.04-56.95%536.64%-0.92%
46
Neutral
£16.29M-9.76-58.72%-9.11%18.91%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:KOO
Kooth
155.00
-25.00
-13.89%
GB:COG
Cambridge Cognition Holdings
35.00
-2.00
-5.41%
GB:IXI
IXICO plc
8.65
-2.85
-24.78%
GB:TRLS
Trellus Health PLC
0.12
-0.68
-85.00%
GB:OPT
Optima Health PLC
192.50
-13.44
-6.53%

Kooth Corporate Events

Business Operations and StrategyExecutive/Board Changes
Kooth Adds US Behavioural Health Veteran James A. Polo to Board
Positive
May 19, 2026
Kooth Plc, a digital mental and behavioural health specialist, delivers online platforms such as Kooth, Qwell and Soluna to more than 20 million users across the UK and US, with a particular focus on youth and under-18s. The group combines self-he...
Business Operations and StrategyFinancial DisclosuresShareholder Meetings
Kooth publishes 2025 annual report and sets date for 2026 AGM
Positive
May 19, 2026
Kooth has published its 2025 annual report, which is now available on the company’s investor website, with physical copies to be sent to shareholders who have requested them. The company also confirmed that its 2026 annual general meeting wi...
Business Operations and StrategyProduct-Related Announcements
Kooth’s Soluna Platform Wins California Backing With Growing Impact on Youth Mental Health
Positive
Apr 20, 2026
Kooth has highlighted an independent impact report from California’s Department of Health Care Services confirming that its Soluna digital behavioural health platform is expanding its reach and delivering effective, safe and cost-efficient m...
Business Operations and StrategyFinancial Disclosures
Kooth Builds US Momentum With Soluna as 2025 Profits Beat Expectations
Positive
Apr 8, 2026
Kooth reported audited 2025 results that underscore a strategic pivot toward long-term, sustainable growth, led by the rapid embedding of its Soluna platform in California’s behavioural health system. By year-end, more than 144,000 young peo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 22, 2026